SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-018461
Filing Date
2020-07-24
Accepted
2020-07-24 07:05:35
Documents
3
Period of Report
2020-07-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea124512-8k_protarathe.htm 8-K 25331
2 PRESS RELEASE, DATED JULY 24, 2020 ea124512ex99-1_protarathe.htm EX-99.1 10117
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3732
  Complete submission text file 0001213900-20-018461.txt   42167
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36694 | Film No.: 201045051
SIC: 2836 Biological Products, (No Diagnostic Substances)